• 12/12/2021

    The acclaimed annual conference for clinicians is held for the first time in Qatar

    Doha, 12 December 2021: Hamad Medical Corporation’s (HMC) National Center for Cancer Care and Research (NCCCR) hosted The Best of ASCO 2021 in Qatar for the first time. 

    The annual conference of the American Society of Clinical Oncology’s (ASCO) is one of the most globally influential events in the cancer academic calendar. It provides a platform where the most important research findings are unveiled and where new ways to manage the treatment and care of cancer patients are agreed.

    The Best of ASCO allows cancer specialists around the world to select the topics most relevant to their own cancer patients and cancer services and present it to a national audience in a two-day event.

    Dr. Mohamed Usama Al Homsi, Senior Consultant in Medical Oncology and Deputy Medical Director for Clinical Research, Education and Quality at NCCCR said: “This conference is a wonderful opportunity for clinicians in Qatar to learn about the latest cancer research and the implications for the diagnosis and treatment in Qatar, including the impact on cancer outcomes from COVID 19. We are fortunate to have been awarded the licence to host this conference and it is hoped that it will become an annual event and be held in person rather than online next year.”

    Led by NCCCR’s team of cancer experts the two-day agenda covered both common and rare, early and late-stage cancers as well as the full range of treatments such as surgery, systemic anti-cancer therapies and radiation oncology. Issues such as quality of life, the management of pain and toxicity as well as the organization of care were also covered. 

    Dr Salha M. Bujassoum, Senior Consultant Hematologist/ Oncologist, Chairperson of Medical Oncology and Palliative Care Medicine, Clinical Leads of Breast Cancer MDT and Director of Cancer Genetics “There were many relevant topics covered in this conference concerning all cancers. We discussed the latest treatments for patients with breast, lung cancer, urological cancers, gastro-intestinal cancers, malignant melanoma gynecological cancers and many more. The scientific abstracts released at the ASCO Annual Meeting, includes the latest findings from cancer clinical trials, including new drug studies, could dramatically change patient care in Qatar and around the world”.